Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

ICE/CED-3 proteasesin apoptosis.

Whyte M.

Trends Cell Biol. 1996 Jul;6(7):245-8.

PMID:
15157443
2.

Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c.

Rossé T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C.

Nature. 1998 Jan 29;391(6666):496-9.

PMID:
9461218
4.

Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation.

Adida C, Crotty PL, McGrath J, Berrebi D, Diebold J, Altieri DC.

Am J Pathol. 1998 Jan;152(1):43-9.

5.

Cytochrome c: can't live with it--can't live without it.

Reed JC.

Cell. 1997 Nov 28;91(5):559-62. Review. No abstract available.

6.

Caspases: intracellular signaling by proteolysis.

Salvesen GS, Dixit VM.

Cell. 1997 Nov 14;91(4):443-6. Review. No abstract available.

7.

The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases.

Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC.

EMBO J. 1997 Dec 1;16(23):6914-25.

8.

Biochemical characteristics of caspases-3, -6, -7, and -8.

Stennicke HR, Salvesen GS.

J Biol Chem. 1997 Oct 10;272(41):25719-23.

9.

Cytochrome c activation of CPP32-like proteolysis plays a critical role in a Xenopus cell-free apoptosis system.

Kluck RM, Martin SJ, Hoffman BM, Zhou JS, Green DR, Newmeyer DD.

EMBO J. 1997 Aug 1;16(15):4639-49.

10.
11.

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.

Ambrosini G, Adida C, Altieri DC.

Nat Med. 1997 Aug;3(8):917-21.

PMID:
9256286
12.

Cell death induction by receptors of the TNF family: towards a molecular understanding.

Wallach D, Boldin M, Varfolomeev E, Beyaert R, Vandenabeele P, Fiers W.

FEBS Lett. 1997 Jun 23;410(1):96-106. Review. No abstract available.

13.

X-linked IAP is a direct inhibitor of cell-death proteases.

Deveraux QL, Takahashi R, Salvesen GS, Reed JC.

Nature. 1997 Jul 17;388(6639):300-4.

PMID:
9230442
14.

Control of apoptosis by proteases.

Thornberry NA, Rosen A, Nicholson DW.

Adv Pharmacol. 1997;41:155-77. Review. No abstract available.

PMID:
9204145
15.

Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis.

Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan ZM, Saxena S, Weichselbaum R, Nalin C, Kufe D.

Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6939-42.

16.

Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.

Krajewski S, Gascoyne RD, Zapata JM, Krajewska M, Kitada S, Chhanabhai M, Horsman D, Berean K, Piro LD, Fugier-Vivier I, Liu YJ, Wang HG, Reed JC.

Blood. 1997 May 15;89(10):3817-25.

17.

Channel formation by antiapoptotic protein Bcl-2.

Schendel SL, Xie Z, Montal MO, Matsuyama S, Montal M, Reed JC.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5113-8.

18.

Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease.

Krajewska M, Wang HG, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC.

Cancer Res. 1997 Apr 15;57(8):1605-13.

19.
20.

Target protease specificity of the viral serpin CrmA. Analysis of five caspases.

Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS.

J Biol Chem. 1997 Mar 21;272(12):7797-800.

Supplemental Content

Support Center